共 8 条
[2]
Spironolactone in the treatment of polycystic ovary syndrome: Effects on clinical features; insulin sensitivity and lipid profile.[J].E. Zulian;P. Sartorato;S. Benedini;G. Baro;D. Armanini;F. Mantero;C. Scaroni.Journal of Endocrinological Investigation.2005, 3

